6919 KangPei Biotech Annual General Meeting Resolutions
NQ Score
46/100
N1 Content Completeness
9
AI Summary (NQ-processed)
KangPei Biotech approved its 2025 financial statements, loss compensation plan, board re-election, and employee stock incentive plans at the AGM on May 22, 2026.
AI Analysis
Frequently Asked Questions
- Q: What was decided at KangPei's AGM?
- A: Resolutions included financial statement approval, board re-election, and new share issuance for employees.